American Journal of Transplantation

Article	Citations
Outside Front Cover	303
Dissecting CMV latency and reactivation: BETing on the epigenetic regulators	292
American Journal of Transplantation: Volume 21, Number 7, July 2021	281
OFC 23rd Winter Symposium	271
Navigating challenges in recipient selection for end-chain kidneys	204
AJT Digest for Patients: Their Own Window into Key Research	199
Dual Kidney Transplantation from Extended Marginal Donors in the United States: An analysis of SRTR and Literature Review	191
Benefits Of Preemptive Transplantation In Older Patients with High KDPI Kidneys: Is Sooner Better Than Later?	171
Disparities in liver transplantation: One size may not fit all	138
Are we closer to abandoning protocol graft biopsies after pediatric liver transplantation?	130
Rethinking Lactate’s Role as a Post-Transplant Outcome Predictor During Normothermic Machine Perfusion: Science or Speculation?	129
Optimization of donor flow matching and portal modulation to decrease small for size syndrome in Living Donor Liver Transplant - A Single Center American Experience	122
Deceased Kidney Donors on Dialysis Create Opportunities for Renal Transplantation: A Single Center Experience	118
Outcomes By Epstein-Barr Virus Serostatus In Pediatric Kidney Transplantation	113
Induction of fetomaternal tolerance? Suppressing B cells!	111
Luminal polyethylene glycol solution delays the onset of preservation injury in the human intestine	109
Hereditary thrombotic thrombocytopenic purpura acquired through liver transplantation: A case report	105
De novo membranous nephropathy in a pig-to-baboon kidney xenograft: A new xenograft glomerulopathy	104
Effects of in vivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates	103
Pediatric cardiac xenotransplantation and stakeholder engagement	101
Increasing Azole-resistant environmental Aspergillus fumigatus in Denmark	100
International multicenter study of ultralow graft-to-recipient weight ratio grafts in adult living donor liver transplantation	92
Phage-display immunoprecipitation for precision mapping the autoreactome	92
Will the flu vaccine work this year?	91
The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients	88

Validation of a novel donor lung scoring system based on the updated lung Composite Allocation Score	86
Pure laparoscopic donor hepatectomy: Experience of 556 cases at Seoul National University Hospital	81
Kaposi sarcoma herpesvirus inflammatory cytokine syndrome—a severe complication of an overlooked donor-derived infection	79
OPTN/SRTR 2021 Annual Data Report: COVID-19	78
SARS-CoV-2 antibody testing for transplant recipients: A tool to personalize protection versus COVID-19	77
Accurate eplet identification is necessary for accurate risk assessment	74
Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: Results of a nationwide study	73
Microbiota and immunoregulation: A focus on regulatory B lymphocytes and transplantation	73
Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients	72
Short- and long-term complications after living donor ileal resection	72
Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave	70
Eculizumab as a therapeutic approach for severe crescentic recurrence of immunoglobulin A nephropathy after kidney transplantation	66
Impact of interleukin-6 on T cells in kidney transplant recipients	66
Alloantibodies after simultaneous liver-kidney transplant: A story of primary nonfunction, retransplantation, and antibody-mediated rejection	66
Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients	66
Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study	65
Polymicrobial bacteremia in a heart transplant recipient: More than what meets the eye	64
Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020	64
An ethical analysis of conditional and partially directed live kidney donation among strangers—The Israeli experience	64
Generating strategies for a national comeback in pancreas transplantation: A Delphi survey and US conference report	64
Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm	63
The benefit to waitlist patients in a national paired kidney exchange program: Exploring characteristics of chain end living donor transplants	62
Development of a natural language processing algorithm to extract social determinants of health from clinician notes	62
First case of rapidly fatal mpox from secondary (household) transmission in a kidney transplant recipient	61
Rejection and graft vasculopathy secondary to effects of Crohn's disease in a heart-transplanted child	61
DCDD heart transplantation with thoraco-abdominal normothermic regional perfusion and static cold storage: The experience in Spain	61
New metrics to measure OPO performance are here: How do we ensure organizations receive feedback and improve organ donation?	61
Long-term outcomes after normothermic machine perfusion in liver transplantation—Experience at a single North American center	60
Dynamic impact of liver allocation policy change on donor utilization	60
Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation	59
Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study	59
Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: A single-center experience	58
Atezolizumab plus bevacizumab as a downstaging therapy for liver transplantation in hepatocellular carcinoma with portal vein thrombosis: The first report	57
OPTN/SRTR 2021 Annual Data Report: Lung	56
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept	56
Corrigendum to ‘Partial Bladder Transplantation with En Bloc Kidney Transplant—The First Case Report of a ‘Bladder Patch Technique’ in a Human’ [American Journal of Transplantation 8 (2008) 1060-1063]	54
A plan to save lives: Hong Kong–mainland China second-tier mutual assistance allocation	54
American Journal of Transplantation: Volume 21, Number 6, June 2021	52
10 degree C static storage of porcine donation after circulatory death livers improves biliary viability and mitigates ischemia-reperfusion injury	52
Spatial multiomics of arterial regions from cardiac allograft vasculopathy rejected grafts reveal novel insights into the pathogenesis of chronic antibody-mediated rejection	51
Increasing liver organ acquisition fees and the risk of a tragedy of the commons	50
Anatomical variations of left hepatic vein and outflow reconstruction techniques in pediatric living donor liver transplantation	50
Prevention of Mollicute transmitted infections from donor lungs after lung transplant	50
Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020–2021	50
Donor programmed cell death 1 ligand 1 is required for organ transplant tolerance in major histocompatibility complex-mismatched mixed chimeras although programmed cell death 1 ligand 1 and major hist	50
Sowing “seeds of trust”: How trust in normothermic regional perfusion is built in a continuum of care	49
Down to the coronary arteries: When spatial multiomics open up a narrow path	49
One Man In His Time Plays Many Parts: Transplant Surgeons’ Approach to Evolution of Career Identity	48
DCD Liver Transplantation- Contemporary US Experience with NRP and NMP	48
The dangerous precedent of censoring scientific dissemination	48

Characterizing Renal Function Predictors and Outcomes in Liver Transplant Recipients Who Have Preoperative Renal Dysfunction	48
Specific human leucocyte antigen-DQ risk epitope mismatches are associated with chronic lung allograft dysfunction after lung transplantation	48
Intranasal therapy of IGFBP2 ameliorates lung fibrosis	47
Rhabdomyolysis Following Living Donor Kidney Donation - an Underreported Entity?	47
Poor Post-Transplantation Renal Function Negatively Impacts Survival of Liver Transplant Recipients Despite SLK and Safety Net Kidney Transplantation	47
Variability in post-transplant outcomes reported by studies examining perfusion techniques in liver transplantation: a qualitative systematic review	47
Controlled Hypothermic Preservation of Donor Livers with Back- to-Base Normothermic Machine Perfusion Improves Clinical Outcomes and Facilitates Donor Pool Expansion	46
CDC guidance on new pentavalent meningococcal vaccine	46
Cell-free DNA method for monitoring porcine-to-human xenotransplants	46
Integrating frailty into clinical care	46
Normothermic ex situ pancreas perfusion for the preservation of porcine pancreas grafts	45
Regarding normothermic regional perfusion: Arguing by insistence is not a strong argument	45
Substantial weight loss resulting in a large panniculus may incur additional pretransplant costs	45
SARS-CoV-2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients	45
The impact of machine perfusion of the heart on warm ischemia time and organ yield in donation after circulatory death	45
First report of auxiliary liver transplantation for severe cholangiopathy after SARS-CoV-2 respiratory infection	45
Second field high-resolution HLA typing for immunologic risk stratification in kidney transplantation	43
The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study	43
MELD-based allocation at 20: Can we evolve and mature?	43
Effectiveness of a culturally competent care intervention in reducing disparities in Hispanic live donor kidney transplantation: A hybrid trial	43
Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring	43
Immunosuppressive therapy after solid organ transplantation and the gut microbiota: Bidirectional interactions with clinical consequences	42
Utilization and outcomes of deceased donor SARS-CoV-2–positive organs for solid organ transplantation in the United States	41
Adjusting for race in metrics of organ procurement organization performance	41
OPTN/SRTR 2023 Annual Data Report: Lung	41
Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!	40
Unexpected incidental finding in a prospective living kidney donor	39
Robotic kidney transplantation from deceased donors: A single-center experience	39
Sex disparity in liver allocation within Eurotransplant	39
Incomplete tissue product tracing during an investigation of a tissue-derived tuberculosis outbreak	39
Novel modified iliac artery stent graft with side branch extension facilitating kidney transplant in severe aortoiliac occlusive disease	39
OPTN/SRTR 2023 Annual Data Report: Kidney	39
The short end of the stick: Access to lung transplantation for short-statured patients in the composite allocation score era	38
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae	38
Back-table intra-arterial administration of C1 esterase inhibitor to deceased donor kidney allografts improves posttransplant allograft function: Results of a randomized double-blind placebo-controlle	38
Body composition and the skeletal muscle compartment in liver transplantation: Turning challenges into opportunities	38
Utilizing pathophysiological concepts of ischemia-reperfusion injury to design renoprotective strategies and therapeutic interventions for normothermic ex vivo kidney perfusion	38
Donor utilization in heart transplant with donation after circulatory death in the United States	37
Characterizing proximity and transfers of deceased organ donors to donor care units in the United States	37
Oxidative stress and related metabolic alterations are induced in ex situ perfusion of donated hearts regardless of the ventricular load or leukocyte depletion	37
ATC 2024 Poster Abstracts	37
“Time is tissue”—A minireview on the importance of donor nephrectomy, donor hepatectomy, and implantation times in kidney and liver transplantation	37
“Horses for courses” computed tomography or predicted total lung capacity for size matching in lung transplantation	36
Stem cell–derived islets take a leap toward patients	36
	35
A 46-year-old male with posttransplant lymphoproliferative disorder and massive hemoptysis following second bilateral lung transplantation	35
Prognostic implications of lung cancers incidentally identified on explant: A joint study of the Scientific Registry of Transplant Recipients and the National Cancer Database	35
TIGIT agonism alleviates costimulation blockade-resistant rejection in a regulatory T cell–dependent manner	35
Utilizing kidneys from a donor with bile-cast nephropathy	35
Continuous donor-recipient age matching: A chance for kidney allocation in the Eurotransplant region	35
Trained immunity: Can we get one transplanted kidney to last a lifetime?	35
Facial skin lesions and diarrhea in a kidney transplant recipient	34
Pancreas transplantation as rescue therapy in a patient with type 1 diabetes and concurrent subcutaneous insulin resistance	34
The current state of transplant advanced practice providers: results of the advanced practice provider practice survey	34
Balancing the live virus vaccine scales: Protection vs risk	34
Low-dose interleukin-2 promotes immune regulation in face transplantation: A pilot study	34
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS 2nd Edition Dharnidharka Vikas R, Green Michael, Webber Steven A, Ulrich Trappe Ralf (ed.), Switzerland: Springer International Publishing, 2021, XIII, 31	33
OPTN/SRTR 2022 Annual Data Report: COVID-19	33
Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair	33
Protecting kidney transplant recipients against SARS-CoV-2 infection: A third dose of vaccine is necessary now	33
Transplant oncology in locally advanced intrahepatic cholangiocarcinoma: One more step on a long road	32
The Role of Race and Socioeconomic Status in Live Donor Kidney Transplant Interest and Evaluation	32
AWAKE Program with rapid discharge in Kidney Transplantation	32
Upper gastrointestinal bleeding in a lung transplant recipient	32
Outside Front Cover	32
Front Page	32
Keep the engine running: Maintaining transplant registry utility in liver transplant	32
The impact of visitation volunteers on the mood, valence, and arousal of liver and kidney transplant patients	32
Outcomes of Single Pediatric Kidney Grafts	32
Targeting CXCR1/2 in the first multicenter, double-blinded, randomized trial in autologous islet transplant recipients	31
Generalizability of kidney transplant data in electronic health records — The Epic Cosmos database vs the Scientific Registry of Transplant Recipients	31
Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023	31
OPTN/SRTR 2021 Annual Data Report: Deceased Organ Donation	31
Circadian clocks drive rhythmic antitumor immune responses mediated by migratory dendritic cells	31
What Can We Learn from analyzing Paired Mate Kidneys Transplanted at the Same Center?	31
Total pancreatectomy with islet cell autotransplantation in a 2-year-old child with hereditary pancreatitis due to a PRSS1 mutation	30
Skin lesions and acute kidney injury in a kidney transplant recipient	30
The 21st Century Cures Act and psychosocial electronic documentation in solid organ transplantation: Potential harms and practical strategies	30
CD47 and PD-L1 overexpression in proliferating human hepatocytes attenuated immune responses and ameliorated acute liver injury in mice	30
Effects of broader geographic distribution of donor lungs on travel mode and estimated costs of organ procurement	30

Treating comorbidity in solid organ transplant recipients as a confounder or a mediator of patient outcomes	30
Letermovir in lung transplant recipients with cytomegalovirus infection: A retrospective observational study	30
Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients	30
Clear data, careful counseling: Discussing cancer risk after living kidney donation	30
Transplantation, HIV Serostatus, and Registry Data: Room for Improvement	30
Subphenotypes of frailty in lung transplant candidates	29
Oropouche virus disease—region of the Americas	29
The landscape of hepatitis C virus infection in pediatric kidney transplantation	29
Motivations and outcomes of compatible living donor–recipient pairs in paired exchange	29
Hemophagocytic syndrome with graft-versus-host disease after liver transplantation: The bone marrow as a not so quiet battlefield?	29
Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center	29
Macrophage-inducible C-type lectin activates B cells to promote T cell reconstitution in heart allograft recipients	28
Impact of the new UNOS donor heart allocation system on waitlist outcomes and early posttransplant mortality among adults with congenital heart disease	28
Interleukin 6 trans-signaling is a critical driver of lung allograft fibrosis	28
In a real-life setting, risk factors, coronary artery calcium score, and coronary stenosis at computed tomography angiography are associated with major adverse cardiovascular events and all-cause mort	28
OPTN/SRTR 2020 Annual Data Report: Lung	28
Liver transplantation for acute liver failure and acute-on-chronic liver failure	28
	28
Impact of Normothermic Machine Perfusion on Liver Transplant Waitlist Times: A Single-Center Matched Cohort	27
The living organ donor as patient: Theory and practice	27
Outcomes in Patients with Incidental Intra-hepatic Cholangiocarcinoma on Explant Pathology after Liver Transplantation	27
Managing Bile Duct and Vascular Variations in Robotic Assisted Living Donor Right Hepatectomy: A Single Center U.S. Experience	27
The thymus hosts liver- and gut-like mimetic cells critical to immune self-tolerance	27
The Comparison of Cellular and Acellular Perfusate for the Dynamic Organ Storage System in a Porcine Donation After Circulatory Death Model	27
Bioengineered Organs: Not a Matter of “If”	27
	27
When is it safe to transplant after cancer–adding data to the decision	26
Importance of malnutrition and frailty in kidney transplant waiting list	26
The individual impact of machine perfusion on liver and kidney in simultaneous liver and kidney transplantation	26
OPTN/SRTR 2023 Annual Data Report: Intestine	25
Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab	25
Bringing palliative care to transplant	25
The concept of immunothrombosis in pancreas transplantation	25
Donor-specific immune senescence as a candidate biomarker of operational tolerance following liver transplantation in adults: Results of a prospective, multicenter cohort study	25
Humoral immune responses against SARS-CoV-2 in transplantation: Actionable biomarker or misplaced trust?	25
Evaluation for genetic disease in kidney transplant candidates: A practice resource	25
White paper on antimicrobial stewardship in solid organ transplant recipients	25
The role of IL-6 in hyperlipidemia-induced accelerated rejection	25
Deceased donor urinary Dickkopf-3 associates with future allograft function following kidney transplantation	25
Mortality among solid organ transplant recipients with a pretransplant cancer diagnosis	24
Tongue ulcer in a pediatric heart transplant recipient	24
Solid organ transplant recipients with tuberculosis disease in California, 2010 to 2020	24
Augmenter of liver regeneration-mediated mitophagy protects against hepatic ischemia/reperfusion injury	24
Surgical site infections after kidney transplantation are independently associated with graft loss	24
The role of bypass filters in deceased donor kidney allocation in the United States	23
Correcting the sex disparity in MELD-Na	23
Gene expression–based molecular scoring of pancreas transplant rejection for a quantitative assessment of rejection severity and resistance to treatment	23
Preformed T cell alloimmunity and HLA eplet mismatch to guide immunosuppression minimization with tacrolimus monotherapy in kidney transplantation: Results of the CELLIMIN trial	23
From flawed to fairer: Reducing blood type bias in lung transplant allocation	23
A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression	23
Diagnosis and treatment of allograft rejection in islet transplantation	23
Belatacept-related cytomegalovirus infection: Advocacy for tailored immunosuppression based on individual assessment of immune fitness	23
The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study	23
A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients	23
Graft-resident donor macrophages functionally regulate transplant outcomes	22
Transplantation pushes into the world of elite sports	22
Expedited lung allocation in the era of continuous distribution	22
Corrigendum to ‘Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: A 2-year diagnostic accuracy study of participants from a randomized controlled trial’ [Amer	22
OPTN/SRTR 2021 Annual Data Report: Introduction	22
Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients	22
American Journal of Transplantation: Volume 21, Number 10, October 2021	22
American Journal of Transplantation: Volume 22, Number 2, February 2022	22
Graft function and incidence of cardiac allograft vasculopathy in donation after circulatory-determined death heart transplant recipients	22
T Cell repopulation after using rATG in a Decedent Xenotransplant Study	22
Macrophage-specific hypoxia inducible factor 2α expression promotes cardiac allograft tolerance	22
Therapeutic Hypothermia vs Normothermia in Kidney Transplantation: A Meta-analysis of Randomized Controlled Trials	22
OPTN/SRTR 2022 Annual Data Report: Heart	22
Memory T follicular helper cells drive donor-specific antibodies independent of memory B cells and primary germinal center and alloantibody formation	22
Multivisceral transplantation utilizing hepatitis C virus–viremic donors for hepatitis C virus–negative recipients	22
Characteristics and Outcomes of Kidneys Accepted versus Turned Down by Regional Centers	22
Corrigendum to ‘Assessment of long-term outcomes post living liver donation highlights the importance of scientific integrity when presenting transplant registry data’ [American Journal of Transplanta	22
Book review	22
ATC 2023 DAAG_Program	22
Unexpected hepatitis B virus infection after liver transplantation — United States, 2014–2019	22
Machine learning–based mortality prediction models using national liver transplantation registries are feasible but have limited utility across countries	21
Partial bladder transplantation with en bloc kidney transplant—long-term, 17 years, the outcome of a “bladder patch technique”	21
OPTN/SRTR 2022 Annual Data Report: Intestine	21
Liver Transplantation for Fulminant Hepatic Failure in a Young Woman	21
Normothermic Machine Perfusion Facilitates Donation After Circulatory Death Liver Transplant In High-Risk Recipients	21
BK DNAemia and native kidney polyomavirus nephropathy following lung transplantation	21
Orthotopic robot-assisted laparoscopic kidney transplantation with living donor: An option for patients excluded from standard heterotopic transplantation	21
First case report of multivisceral transplant from a deceased cardiac death donor	21
Recipient sex and estradiol levels affect transplant outcomes in an age-specific fashion	21
Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations	20
The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program	20
Time to reconsider the role of donor hepatitis C status in the Kidney Donor Risk Index	20
Association of transplant center market concentration and local organ availability with deceased donor kidney utilization	20
Response to “Public attitude to imminent death donation”	20
Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort	20
The failing kidney allograft: A review and recommendations for the care and management of a complex group of patients	20
Association of organ procurement organization volume with Centers for Medicare and Medicaid Services performance evaluations	20
Repeat SARS-CoV-2 testing after recovery. Is a pretransplant PCR necessary?	20
Multiple liver lesions in a lung transplant recipient	20
Hepatitis C–associated focal proliferative glomerulonephritis in an aviremic recipient of a hepatitis C–positive antibody donor liver	20
Banff and ABMR: Are we going in the right direction?	20